Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 81 Neoplasms, Plasma Cell 27 Neoplasms 13 Brain Neoplasms 11 Prostatic Neoplasms 10 Central Nervous System Neoplasms 10 Melanoma 9 Leukemia 9 Glioblastoma 8 Gliosarcoma 7 Glioma 7 Leukemia, Lymphocytic, Chronic, B-Cell 6 Carcinoma, Hepatocellular 6 Recurrence 5 Myeloproliferative Disorders 5 Myelodysplastic Syndromes 5 Lymphoma, Mantle-Cell 5 Lung Neoplasms 5 Waldenstrom Macroglobulinemia 4 Sarcoma 4 Myelodysplastic-Myeloproliferative Diseases 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4 Immunoglobulin Light-chain Amyloidosis 4 Carcinoma, Renal Cell 4 Uveal Melanoma 3 Oligodendroglioma 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3

Interventions

Megestrol Acetate 4 Mirtazapine 2 Infliximab 2 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Palonosetron 1 Olanzapine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Gemcitabine 1 Etanercept 1 Eicosapentaenoic Acid 1 Dronabinol 1 Docetaxel 1 Creatine 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anorexia × Thalidomide × Clear all

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡